Xencor (XNCR) Stock Performance
Xencor (ticker XNCR) increased by 7.55 % during a 24‑hour period ending at 05:29 AM Central Europe on Thursday, 22 October 2026.
- Current trading price: USD 25.16 per share.
- Shares outstanding: 74.2 million.
- Market capitalization: USD 1.7 billion.
- Trading volume (last 24 h): USD 22.1 million.
- Change since last month‑end: down 0.36 %.
- 200‑day simple moving average: USD 16.4.
- 52‑week high: USD 30.61 (25 August 2026).
- 52‑week low: USD 10.38 (19 May 2026).
Recent Performance of Peer Stocks
| Symbol | 24‑hour change | Current price | Market cap | P/E ratio |
|---|---|---|---|---|
| SRCE (1st Source) | +1.35 % | USD 85.81 | USD 2.1 bn | 12.26 |
| INSP (Inspire Medical) | +1.70 % | USD 71.07 | USD 2.0 bn | 15.15 |
| TILE (Interface) | +0.56 % | USD 35.07 | USD 2.1 bn | 14.50 |
| KRP (Kimbell Royalty) | +1.10 % | USD 16.44 | USD 2.0 bn | 19.40 |
| BCRX (Biocryst) | –1.61 % | USD 7.75 | USD 2.1 bn | – |
Company Overview
Xencor, Inc. is a biotechnology firm focused on developing antibody and protein therapeutics for cancer and autoimmune inflammation. The company distributes its products worldwide to healthcare providers and facilities. Xencor is listed on the Nasdaq, and its website is www.xencor.com . The company went public on 3 December 2013.
